[Adams RJ, Appleton SL, Gill TK, Taylor AW, Wilson DH, Hill CL. (2011). Cause for concern in the use of non-steroidal anti-infl ammatory medications in the community - a population-based study. BMC Family Practice 12: 70.]Search in Google Scholar
[Arellano F, Sacristan JA. (1990). Metamizole: reassessment of its therapeutic role. Eur J Clin Pharmacol 38( 6 ): 617-619.]Search in Google Scholar
[Bresalier RS, Sandler RS, Quan H. (2005). Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. New Engl J Med 352(11): 1092-1102.]Search in Google Scholar
[Cannon PJ. (1986). Prostaglandins in congestive heart failure and the eff ects of nonsteroidal anti-infl ammatory drugs. Am J Med 81: 123-32.]Search in Google Scholar
[Cullen G, Kelly E, Murray FE. (2006). Patients´ knowledge of adverse reactions to current medications. Br J Clin Pharmacol 62(2): 232-236.]Search in Google Scholar
[Douthwaite AH. (1938). Recent advances in medical diagnosis and treatment. Brit Med J 1: 1143-1146.]Search in Google Scholar
[Hudec R, Kriska M, Bozekova L, Foltan V. (2008). Comparison of NSAID consumption in Slovakia, Finland and Norway. Bratisl Lek Listy 109(8): 370-373.]Search in Google Scholar
[Johnson AG, Nguyen TV, Day RO. (1994). Do nonsteroidal anti-infl ammatory drugs aff ect blood pressure? A meta-analysis. Ann Intern Med 121(4): 289-300.]Search in Google Scholar
[Lanas AI. (2001). Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. Am J Med 110(1A): 70S-73S.]Search in Google Scholar
[McGettigan P, Henry D. (2011). Cardiovascular risk with non-steroidal anti-infl ammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 8(9): e1001098.]Search in Google Scholar
[Mukherjee D. (2002). Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Biochem Pharmacol 63(5): 817-821.]Search in Google Scholar
[Staessen J, Fagard R, Lijnen P, Moerman E, De Schaepdryver A, Amery A. (1983). Eff ects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man. J Hypertens 1: 123-30.]Search in Google Scholar
[Trelle S, Reichenbach S, Wandel S et al. (2011). Cardiovascular safety of nonsteroidal anti-infl ammatory drugs: network meta-analysis. Brit Med J 342: c7086.]Search in Google Scholar
[Walshe JJ, Venuto RC. (1979). Acute oliguric renal failure induced by indomethacin: possible mechanism. Ann Intern Med 91: 47-49. ]Search in Google Scholar
